-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Verastem, Lowers Price Target to $18

Benzinga·11/06/2026 19:18:05
RBC Capital analyst Leonid Timashev maintains Verastem (NASDAQ:VSTM) with a Outperform and lowers the price target from $19 to $18.